BUSINESS NEWS
BioLife Solutions Receives Patent for Cell Preservation Technology
BioLife Solutions has been granted a US patent that covers the methods and compositions for the preservation of cells, tissues or organs in an artificial environment.
Article
Dendreon Signs Agreement to Lease Manufacturing Facility in New Jersey
Dendreon Corporation today announced that it has signed an agreement to lease 158,242 square feet of commercial manufacturing space in Hanover, New Jersey.
Article
Dendreon Appoints Michelle Burris Senior Vice President and Chief Financial Officer
Dendreon Corporation today announced the appointment of Michelle Burris as senior vice president and chief financial officer.
Article
Dyax Corp. And Merck KGaA Enter Into License Agreement For Discovery Of Therapeutic Antibodies And Peptides
Dyax Corp. announced today that it has granted a non-exclusive license to its proprietary phage display libraries to Merck KGaA (Darmstadt, Germany) for the discovery and development of therapeutic antibodies and peptides.
Article
Cryo StemCell Teams up With StemLife, Malaysia for Stem Cell R&D
Cryo StemCell Karnataka Pvt. Ltd., a stem cell bank for storage of umbilical cord, has inked a pact with Malaysia-based StemLife to sustain research and knowledge sharing in the field of stem cell research and development.
Article
Cryo-Cell International Board Appoints Mercedes Walton As Chief Executive Officer
The Board of Directors of CRYO-CELL International Inc. (the “Company”), the world’s largest family cord blood bank, announced today that Mercedes Walton has been appointed Chief Executive Officer for the Company and has executed a three-year contract, effective September 1, 2005.
Article
Genmab A/S Initiates HuMax(R)-CD20 Phase II Study In Rheumatoid Arthritis
Genmab A/S announced today it has initiated a Phase II study with HuMax-CD20 to treat patients with active rheumatoid arthritis (RA) who have failed one treatment with one or more disease modifying anti-rheumatic drugs (DMARDs).
Article
ImClone, UCB to Develop Tumor Antibody
ImClone Systems and UCB have entered into a partnership for the development and commercialization of CDP-791, a novel, investigational antibody targeting the vascular endothelial growth factor receptor-2 (VEGFR-2) that is currently being developed by UCB.
Article
Targepeutics, Inc. Announces Patent License Agreement With National Institutes of Health (NIH)
Combined with Targepeutics’ other exclusively licensed issued patents and several pending applications, these additionally patents give Targepeutics broad rights to commercialize its Genetically Engineered Interleukin 13 (IL-13) platform.
Article
Pegasus Biologics, Inc. Receives FDA Approval to Market OrthADAPT(TM) Bioimplants
Pegasus Biologics, Inc. developers of novel bioimplants using proprietary technologies announced that the FDA has granted a 510K for the OrthADAPT(TM) Bioimplant, an intelligent, adaptable biologic scaffold which fortifies and promotes tissue remodeling while retaining long-term strength.
Article
Pfizer to Acquire Privately Held Bioren
Pharmaceutical giant Pfizer Inc. on Monday said it has agreed to acquire all the outstanding stock of San Carlos, Calif.-based Bioren Inc., a privately held company focused on antibody optimization technologies.
Article
MARKET REPORTS
Malachite Management has joined forces with established and reputable authors and publishers to bring you the following market reports outlining the very latest in Cell Therapy, Gene Therapy, and Immunotherapeutic approaches to Cancer.
“Cell Therapy – Technologies, Markets, and Companies” is over 400 pages of the basic technologies, clinical applications, market analysis, and company profiles related to the cell therapy industry worldwide.
For more information, including order forms, please see:
Cell Therapy Report Summary
Cell Therapy Sample Chapter
Cell Therapy Table of Contents Vol. 1 Vol. 2
Cell Therapy Order Form
“Gene Therapy – Technologies, Markets, and Companies” is over 500 pages of the basic technologies, clinical applications, market analysis, and company profiles related to the gene therapy industry worldwide.
For more information, including order forms, please see:
Gene Therapy Report Summary
Gene Therapy Table of Contents Vol. 1 Vol. 2
Gene Therapy Order Form
The Immunotherapy Reports cover the most recent developments in the immunotherapeutic approaches to cancer.
A Shift in Cancer Immunotherapy Strategies?
Immunotherapy Strategies Executive Summary
Immunotherapy Strategies Table of Contents
Future Perspectives in Cancer Immunotherapy
Future Perspectives Executive Summary
Future Perspectives Table of Contents